Curis (CRIS) Operating Leases (2019 - 2026)
Curis (CRIS) reported Operating Leases of $108000.0 for Q1 2026, down 91.93% on a YoY basis from $1.3 million in Q1 2025, and down 74.77% quarter-over-quarter from $428000.0 in Q4 2025.
Curis (CRIS) Operating Leases (2019 - 2026) Analysis & Trends
Curis has reported Operating Leases for 8 years, with the latest figure at $108000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 91.93% year-over-year to $108000.0; the trailing twelve-month figure through Mar 2026 stood at $108000.0 (down 91.93% YoY), and the FY2025 full-year result was $428000.0, down 85.51% from the prior year.
- Operating Leases for Q1 2026 stood at $108000.0, down from $428000.0 in the prior quarter.
- The five-year high for Operating Leases was $4.5 million in Q2 2022, with the low at $108000.0 in Q1 2026.
- Historically, Operating Leases has averaged $2.5 million across 5 years, with a median of $2.8 million in 2022.
- Annual changes were most pronounced in 2024 — Operating Leases surged 98.39% — and 2026, when it plunged 91.93%.
- Curis' Operating Leases stood at $2.8 million in 2022, then sank by 46.82% to $1.5 million in 2023, then surged by 98.39% to $3.0 million in 2024, then plunged by 85.51% to $428000.0 in 2025, then tumbled by 74.77% to $108000.0 in 2026.
- The last three Operating Leases figures came in at $108000.0 (Q1 2026), $428000.0 (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 428,000.00 |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 2.95 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 3.10 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.70 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 4.50 Mn |
| Mar 31, 2022 | 2.94 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 4.54 Mn |
| Jun 30, 2021 | 5.30 Mn |